BRPI0512049A - usos antivirais de complexos de ácido borìnico - Google Patents

usos antivirais de complexos de ácido borìnico

Info

Publication number
BRPI0512049A
BRPI0512049A BRPI0512049-7A BRPI0512049A BRPI0512049A BR PI0512049 A BRPI0512049 A BR PI0512049A BR PI0512049 A BRPI0512049 A BR PI0512049A BR PI0512049 A BRPI0512049 A BR PI0512049A
Authority
BR
Brazil
Prior art keywords
acid complexes
boronic acid
antiviral
antiviral uses
complexes
Prior art date
Application number
BRPI0512049-7A
Other languages
English (en)
Portuguese (pt)
Inventor
Carolyn Bellinger-Kawahara
Kirk R Maples
Jacob J Plattner
Original Assignee
Anacor Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anacor Pharmaceuticals Inc filed Critical Anacor Pharmaceuticals Inc
Publication of BRPI0512049A publication Critical patent/BRPI0512049A/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/69Boron compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/16Antivirals for RNA viruses for influenza or rhinoviruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • A61P31/22Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BRPI0512049-7A 2004-06-14 2005-06-14 usos antivirais de complexos de ácido borìnico BRPI0512049A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US57941904P 2004-06-14 2004-06-14
PCT/US2005/020978 WO2006085932A2 (en) 2004-06-14 2005-06-14 Anti-viral uses of borinic acid complexes

Publications (1)

Publication Number Publication Date
BRPI0512049A true BRPI0512049A (pt) 2008-02-06

Family

ID=36623539

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0512049-7A BRPI0512049A (pt) 2004-06-14 2005-06-14 usos antivirais de complexos de ácido borìnico

Country Status (12)

Country Link
US (1) US7393856B2 (enExample)
EP (1) EP1765360B1 (enExample)
JP (1) JP2008502694A (enExample)
AT (1) ATE447960T1 (enExample)
BR (1) BRPI0512049A (enExample)
CA (1) CA2570577A1 (enExample)
DE (1) DE602005017626D1 (enExample)
ES (1) ES2333244T3 (enExample)
MX (1) MXPA06014417A (enExample)
PT (1) PT1765360E (enExample)
TW (1) TW200612967A (enExample)
WO (1) WO2006085932A2 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2008130902A (ru) * 2005-12-28 2010-02-10 Анакор Фармасьютикалз, Инк. (Us) Способ получения пиколинатбориновых сложных эфиров
RS54108B1 (sr) 2006-02-16 2015-12-31 Anacor Pharmaceuticals Inc. Mali molekuli koji sadrže boron kao agensi protiv zapaljenja
US8853424B2 (en) 2008-08-11 2014-10-07 Japan Science And Technology Agency Protein cross-linking inhibitor
US8980544B2 (en) 2012-11-27 2015-03-17 The Penn State Research Foundation Boronic and borinic acid compounds as inhibitors of sulfenic acid-containing proteins
US10070649B2 (en) 2013-01-30 2018-09-11 Agrofresh Inc. Volatile applications against pathogens
MX356059B (es) 2013-01-30 2018-05-11 Dow Agrosciences Llc Uso de benzoxaboroles como agentes antimicrobianos volatiles en carnes, plantas, o partes de plantas.
US11039617B2 (en) 2013-01-30 2021-06-22 Agrofresh Inc. Large scale methods of uniformly coating packaging surfaces with a volatile antimicrobial to preserve food freshness
US9585396B2 (en) 2013-01-30 2017-03-07 Agrofresh Inc. Volatile applications against pathogens
US8669207B1 (en) 2013-01-30 2014-03-11 Dow Agrosciences, Llc. Compounds and compositions
KR101756785B1 (ko) 2015-03-10 2017-07-12 한국화학연구원 4배위 유기 붕소 화합물의 제조방법
EP3426029B1 (en) 2016-03-07 2023-08-30 AgroFresh Inc. Synergistic methods of using benzoxaborole compounds and preservative gases as an antimicrobial for crops
EP3609504A4 (en) 2017-03-01 2021-03-03 Anacor Pharmaceuticals, Inc. NEW OXABOROLE ANALOGUES AND USES OF THE LATEST
TWI883391B (zh) * 2020-02-18 2025-05-11 美商基利科學股份有限公司 抗病毒化合物
US20230340530A1 (en) 2020-08-31 2023-10-26 Pfizer Inc. Methods of Protecting RNA

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5788800A (en) 1999-07-07 2001-01-22 Du Pont Pharmaceuticals Company Peptide boronic acid inhibitors of hepatitis c virus protease
JP2006511613A (ja) * 2002-12-18 2006-04-06 アナコア ファーマシューティカルズ インコーポレイテッド ボロン酸複合体を含む抗生物質および使用法

Also Published As

Publication number Publication date
JP2008502694A (ja) 2008-01-31
ATE447960T1 (de) 2009-11-15
WO2006085932A3 (en) 2006-10-05
US7393856B2 (en) 2008-07-01
TW200612967A (en) 2006-05-01
PT1765360E (pt) 2009-12-24
WO2006085932A2 (en) 2006-08-17
CA2570577A1 (en) 2006-08-17
EP1765360B1 (en) 2009-11-11
HK1102702A1 (en) 2007-11-30
US20060019927A1 (en) 2006-01-26
DE602005017626D1 (de) 2009-12-24
MXPA06014417A (es) 2007-03-08
EP1765360A2 (en) 2007-03-28
ES2333244T3 (es) 2010-02-18

Similar Documents

Publication Publication Date Title
BRPI0512108A (pt) antibióticos contendo complexos de ácido borìnico e métodos de uso
BRPI0512049A (pt) usos antivirais de complexos de ácido borìnico
NO20060091L (no) Anvendelse av kondenserte heterocykliske forbindelser som SCCE-inhibitorer for behandling av hudproblemer eller kreft
BRPI0418251C1 (pt) fosfonatos, monofosfonamidatos, bisfosfonamidatos, e, composição farmacêutica os compreendendo
ECSP11010949A (es) Inhibidores de las enzimas de proteína cinasa activadas por mitógeno p38
CR20110230A (es) Inhibidores de las enzimas de proteina cinasa activadas por mitogeno p38
ATE387450T1 (de) Meso-substituierte porphyrine
BR0207811A (pt) Compostos de uréia aril e heteroaril substituìdos úteis no tratamento de doenças
EA200800564A1 (ru) Производные ксантина как селективные агонисты нм74а
DE602004017194D1 (de) Pyridylpyrrol-derivate als wirksame kinase-hemmer
BR112012032234A2 (pt) "derivados de heteroaril imidazolona como inibidores de jak".
EA200970595A1 (ru) Производные замещенных индазолов, активные в качестве ингибиторов киназ
CR10358A (es) Pirido[3,2-e] pirazinas, su uso como inhibidores de fosfodiesterasa 10, y procesos para prepararlos
EA201291310A1 (ru) Композиция ингибитора jak для местного применения
BR112015007231A2 (pt) derivados de pirroltriazinona como inibidores de pi3k
BR0317564A (pt) Compostos, composições e métodos para tratar doenças causadas por bactérias ou fungos
ECSP11011113A (es) Piridiloxi-indoles inhibidores del vegf-r2 y uso de los mismos para el tratamiento de enfermedades
DOP2010000390A (es) Compuestos de piridina
ATE514699T1 (de) Substituierte pyrrolopyrazolderivate als kinaseinhibitoren
UY28271A1 (es) Compuestos químicos
BRPI0615270A2 (pt) pirazol fundido como inibidores de p38 map cinase
NO20074944L (no) Heteroarylureaderivater anvendlige for inhibering av CHK1
BRPI0513513A (pt) composto ou um sal farmaceuticamente aceitável do mesmo, processo para preparar o mesmo, composição farmacêutica, uso de um composto ou um sal farmaceuticamente aceitável do mesmo, e, métodos para produzir um efeito inibitório de eg5 e um efeito anticáncer em um animal de sangue quente, e para tratar carcinomas em um animal de sangue quente
UY28366A1 (es) Compuestos químicos
NO20074780L (no) Heterocyklylamidsubstituerte imidazoler

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2158 DE 15/05/2012.